Last Updated:
Name Designation Appointment Date Status
Uwe Hurth

Appointed as Director since December 2017

Director 05-Dec-2017 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Boris Georg Roeder

Appointed as Director since September 2006

Director 27-Sep-2006 Current
Rohit Jain

Appointed as Managing Director since April 2020

Managing Director 01-Apr-2020 Current

People Timeline

Explore the timeline of key personnel in Ursapharm India Private Limited's leadership journey.

Loading...
Contact Details
  • Address Plot No. : A-1, Ground Floor, Fiee Complex, Okhla Industrial Area Phas, E-Ii, New Delhi Delhi, 110020, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Ursapharm India Private Limited?
You can contact Ursapharm India Private Limited through their registered address at Plot No. : A-1, Ground Floor, Fiee Complex, Okhla Industrial Area Phas, E-Ii, New Delhi Delhi, 110020, India, or via their website at ursapharm.in. Social media links are also provided where applicable.
Who are the current directors of Ursapharm India Private Limited?
The current directors of Ursapharm India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • UWE HURTH
  • BORIS GEORG ROEDER
  • ROHIT JAIN
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available